{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:35:17Z","timestamp":1789608917556,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001106","name":"New South Wales Workers' Compensation Dust Disease Board","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/501100001106","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00520-019-04760-x","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:17:30Z","timestamp":1554337050000},"page":"4675-4686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A survey of patient and caregiver experience with malignant pleural mesothelioma"],"prefix":"10.1007","volume":"27","author":[{"given":"Anne","family":"Warby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haryana M.","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5739-5790","authenticated-orcid":false,"given":"Janette L.","family":"Vardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"issue":"9483","key":"4760_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","volume":"366","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Musk AW, Lake RA (2005) Malignant mesothelioma. Lancet 366(9483):397\u2013408. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(05)67025-0","journal-title":"Lancet"},{"issue":"11","key":"4760_CR2","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1445-5994.2010.02223.x","volume":"40","author":"SC Kao","year":"2010","unstructured":"Kao SC, Reid G, Lee K, Vardy J, Clarke S, van Zandwijk N (2010) Malignant mesothelioma. Intern Med J 40(11):742\u2013750. \n                    https:\/\/doi.org\/10.1111\/j.1445-5994.2010.02223.x","journal-title":"Intern Med J"},{"issue":"14","key":"4760_CR3","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21(14):2636\u20132644. \n                    https:\/\/doi.org\/10.1200\/JCO.2003.11.136","journal-title":"J Clin Oncol"},{"issue":"28","key":"4760_CR4","doi-asserted-by":"publisher","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"23","author":"JP Meerbeeck van","year":"2005","unstructured":"van Meerbeeck JP, Gaafar R, Manegold C, Van Klaveren RJ, Van Marck EA, Vincent M, Legrand C, Bottomley A, Debruyne C, Giaccone G, European Organisation for Research, Treatment of Cancer Lung Cancer Group, National Cancer Institute of Canada (2005) Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol 23(28):6881\u20136889. \n                    https:\/\/doi.org\/10.1200\/JCO.20005.14.589","journal-title":"J Clin Oncol"},{"issue":"6","key":"4760_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1556-0864(15)30366-X","volume":"1","author":"P Ellis","year":"2006","unstructured":"Ellis P, Davies AM, Evans WK, Haynes AE, Lloyd NS (2006) Lung Cancer Disease Site Group of Cancer Care Ontario\u2019s Program in Evidence-based C (2006) The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline. J Thorac Oncol 1(6):591\u2013601","journal-title":"J Thorac Oncol"},{"issue":"15","key":"4760_CR6","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1200\/JCO.2004.09.147","volume":"22","author":"AK Nowak","year":"2004","unstructured":"Nowak AK, Stockler MR, Byrne MJ (2004) Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module. J Clin Oncol 22(15):3172\u20133180. \n                    https:\/\/doi.org\/10.1200\/JCO.2004.09.147","journal-title":"J Clin Oncol"},{"key":"4760_CR7","first-page":"Abstract 2496","volume":"22","author":"RJ Gralla","year":"2003","unstructured":"Gralla RJ, Hollen PJ, Liepa AM et al (2003) Improving quality of life in patients with malignant pleural mesothelioma: results of the randomized pemetrexed + cisplatin vs. cisplatin trial using the LCSS-Meso instrument. Proc Am Soc Clin Oncol Meet 22:Abstract 2496","journal-title":"Proc Am Soc Clin Oncol Meet"},{"issue":"6","key":"4760_CR8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.hoc.2005.09.003","volume":"19","author":"H Clayson","year":"2005","unstructured":"Clayson H, Seymour J, Noble B (2005) Mesothelioma from the patient\u2019s perspective. Hematol Oncol Clin North Am 19(6):1175\u20131190, viii. \n                    https:\/\/doi.org\/10.1016\/j.hoc.2005.09.003","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"4760_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2354.2009.01162.x","volume":"19","author":"S Moore","year":"2010","unstructured":"Moore S, Darlison L, Tod AM (2010) Living with mesothelioma. A literature review. Eur J Cancer Care (Engl) 19(4):458\u2013468. \n                    https:\/\/doi.org\/10.1111\/j.1365-2354.2009.01162.x","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"7","key":"4760_CR10","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/pon.3162","volume":"22","author":"A Arber","year":"2013","unstructured":"Arber A, Spencer L (2013) It\u2019s all bad news\u2019: the first 3\u00a0months following a diagnosis of malignant pleural mesothelioma. Psychooncology 22(7):1528\u20131533. \n                    https:\/\/doi.org\/10.1002\/pon.3162","journal-title":"Psychooncology"},{"issue":"3","key":"4760_CR11","first-page":"1183","volume":"9","author":"SF Lee","year":"2009","unstructured":"Lee SF, O'Connor MM, Chapman Y, Hamilton V, Francis K (2009) A very public death: dying of mesothelioma and asbestos-related lung cancer (M\/ARLC) in the Latrobe Valley, Victoria, Australia. Rural Remote Health 9(3):1183","journal-title":"Rural Remote Health"},{"key":"4760_CR12","first-page":"S1240","volume-title":"IALSC World Conference on Lung Cancer","author":"H Dhillon","year":"2013","unstructured":"Dhillon H, Warby A, Kao SC, Vardy J (2013) Chemotherapy for malignant mesothelioma: patient, caregiver and health professionals\u2019 perceptions of treatment and what influences access. In: IALSC World Conference on Lung Cancer. J Thorac Oncol, Sydney, p S1240"},{"issue":"9","key":"4760_CR13","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/0895-4356(92)90110-9","volume":"45","author":"LF Degner","year":"1992","unstructured":"Degner LF, Sloan JA (1992) Decision making during serious illness: what role do patients really want to play? J Clin Epidemiol 45(9):941\u2013950","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"4760_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0272989X03256005","volume":"23","author":"JC Brehaut","year":"2003","unstructured":"Brehaut JC, O'Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E, Feldman-Stewart D (2003) Validation of a Decision Regret Scale. Med Decis Mak 23(4):281\u2013292. \n                    https:\/\/doi.org\/10.1177\/0272989X03256005","journal-title":"Med Decis Mak"},{"issue":"4","key":"4760_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/pon.1067","volume":"16","author":"J Sheehan","year":"2007","unstructured":"Sheehan J, Sherman KA, Lam T, Boyages J (2007) Association of information satisfaction, psychological distress and monitoring coping style with post-decision regret following breast reconstruction. Psychooncology 16(4):342\u2013351. \n                    https:\/\/doi.org\/10.1002\/pon.1067","journal-title":"Psychooncology"},{"issue":"2","key":"4760_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377\u2013381. \n                    https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"issue":"9","key":"4760_CR17","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1038\/bjc.2014.478","volume":"111","author":"A Linton","year":"2014","unstructured":"Linton A, Pavlakis N, O'Connell R, Soeberg M, Kao S, Clarke S, Vardy J, van Zandwijk N (2014) Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales. Br J Cancer 111(9):1860\u20131869. \n                    https:\/\/doi.org\/10.1038\/bjc.2014.478","journal-title":"Br J Cancer"},{"issue":"4","key":"4760_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1445-5994.2012.02925.x","volume":"43","author":"SC Kao","year":"2013","unstructured":"Kao SC, Clarke S, Vardy J, Corte P, Clarke C, van Zandwijk N (2013) Patterns of care for malignant pleural mesothelioma patients compensated by the Dust Diseases Board in New South Wales, Australia. Intern Med J 43(4):402\u2013410. \n                    https:\/\/doi.org\/10.1111\/j.1445-5994.2012.02925.x","journal-title":"Intern Med J"},{"key":"4760_CR19","unstructured":"Australian Bureau of Statistics (ABS): Australian Statistical Geography Standard (ASGS) (2011). Statistics ABo. edn., Canberra: Australian Capital Territory"},{"issue":"1","key":"4760_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/ajco.12306","volume":"11","author":"SC Kao","year":"2015","unstructured":"Kao SC, van Zandwijk N, Clarke S, Vardy J, Lumba S, Tognela A, Ng W (2015) Estimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: an evidence-based benchmark for cancer care. Asia Pac J Clin Oncol 11(1):85\u201392. \n                    https:\/\/doi.org\/10.1111\/ajco.12306","journal-title":"Asia Pac J Clin Oncol"},{"issue":"6","key":"4760_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1177\/0272989X16636113","volume":"36","author":"MM Becerra Perez","year":"2016","unstructured":"Becerra Perez MM, Menear M, Brehaut JC, Legare F (2016) Extent and predictors of decision regret about health care decisions: a systematic review. Med Decis Mak 36(6):777\u2013790. \n                    https:\/\/doi.org\/10.1177\/0272989X16636113","journal-title":"Med Decis Mak"},{"key":"4760_CR22","doi-asserted-by":"crossref","unstructured":"Hollen PJ, Gralla R, Coyne B, Hall R, Genzler R, Cheng H, Weiss G, Gildersleeve J, Hinton I, Crawford J, Rosen L, Lesser M Do patients treated with chemotherapy for advanced NSCLC regret having received treatment? A prospective evaluation in 164 patients. In: IASLC World Conference on Lung Cancer, Yokohama, 2017. vol 11. J Thorac Oncol, p S1834","DOI":"10.1016\/j.jtho.2017.09.523"},{"issue":"8","key":"4760_CR23","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733\u2013742. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1000678","journal-title":"N Engl J Med"},{"issue":"13","key":"4760_CR24","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1200\/JCO.2014.58.7824","volume":"33","author":"JN Dionne-Odom","year":"2015","unstructured":"Dionne-Odom JN, Azuero A, Lyons KD, Hull JG, Tosteson T, Li Z, Li Z, Frost J, Dragnev KH, Akyar I, Hegel MT, Bakitas MA (2015) Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: outcomes from the ENABLE III randomized controlled trial. J Clin Oncol 33(13):1446\u20131452. \n                    https:\/\/doi.org\/10.1200\/JCO.2014.58.7824","journal-title":"J Clin Oncol"},{"key":"4760_CR25","doi-asserted-by":"crossref","unstructured":"Brims FG, Gunatilake S, Lawrie I (2017) RESPECT-MESO: an international randomised controlled trial to assess early specialist palliative care in malignant pleural mesothelioma. In: IASLC World Conference on Lung Cancer, Yokohama, Japan. vol 11. J Thorac Oncol, pp S1747\u2013S1748","DOI":"10.1016\/j.jtho.2017.09.331"},{"issue":"5","key":"4760_CR26","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/cncr.25695","volume":"117","author":"GR Palos","year":"2011","unstructured":"Palos GR, Mendoza TR, Liao KP, Anderson KO, Garcia-Gonzalez A, Hahn K, Nazario A, Ramondetta LM, Valero V, Lynch GR, Jibaja-Weiss ML, Cleeland CS (2011) Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer. Cancer 117(5):1070\u20131079. \n                    https:\/\/doi.org\/10.1002\/cncr.25695","journal-title":"Cancer"},{"issue":"10","key":"4760_CR27","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/pon.1670","volume":"19","author":"U Stenberg","year":"2010","unstructured":"Stenberg U, Ruland CM, Miaskowski C (2010) Review of the literature on the effects of caring for a patient with cancer. Psychooncology 19(10):1013\u20131025. \n                    https:\/\/doi.org\/10.1002\/pon.1670","journal-title":"Psychooncology"},{"issue":"1","key":"4760_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/pon.4441","volume":"27","author":"KM Trevino","year":"2018","unstructured":"Trevino KM, Prigerson HG, Maciejewski PK (2018) Advanced cancer caregiving as a risk for major depressive episodes and generalized anxiety disorder. Psychooncology 27(1):243\u2013249. \n                    https:\/\/doi.org\/10.1002\/pon.4441","journal-title":"Psychooncology"},{"issue":"19","key":"4760_CR29","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1002\/cncr.29505","volume":"121","author":"KM Trevino","year":"2015","unstructured":"Trevino KM, Maciejewski PK, Epstein AS, Prigerson HG (2015) The lasting impact of the therapeutic alliance: patient-oncologist alliance as a predictor of caregiver bereavement adjustment. Cancer 121(19):3534\u20133542. \n                    https:\/\/doi.org\/10.1002\/cncr.29505","journal-title":"Cancer"},{"issue":"11","key":"4760_CR30","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1176\/ajp.153.11.1484","volume":"153","author":"HG Prigerson","year":"1996","unstructured":"Prigerson HG, Bierhals AJ, Kasl SV, Reynolds CF 3rd, Shear MK, Newsom JT, Jacobs S (1996) Complicated grief as a disorder distinct from bereavement-related depression and anxiety: a replication study. Am J Psychiatry 153(11):1484\u20131486. \n                    https:\/\/doi.org\/10.1176\/ajp.153.11.1484","journal-title":"Am J Psychiatry"},{"issue":"6","key":"4760_CR31","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1089\/jpm.2011.0466","volume":"15","author":"P Hudson","year":"2012","unstructured":"Hudson P, Remedios C, Zordan R, Thomas K, Clifton D, Crewdson M, Hall C, Trauer T, Bolleter A, Clarke DM, Bauld C (2012) Guidelines for the psychosocial and bereavement support of family caregivers of palliative care patients. J Palliat Med 15(6):696\u2013702. \n                    https:\/\/doi.org\/10.1089\/jpm.2011.0466","journal-title":"J Palliat Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-04760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-019-04760-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-04760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T08:19:57Z","timestamp":1585901997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-019-04760-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4760"],"URL":"https:\/\/doi.org\/10.1007\/s00520-019-04760-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"3 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Drs Vardy, Dhillon, and Kao report grants from icare Dust Diseases Care for the conduct of the study which is the basis of the submitted work. Dr. Kao reports personal fees to his institution from MSD, Roche, AstraZeneca, Pfizer, and BMS, outside the submitted work. Dr. Dhillon reports honoraria paid to her institution from MSD outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}